Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
19.81
+0.60 (3.14%)
Nov 5, 2024, 11:14 AM EST - Market open
Avanos Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Avanos Medical.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Avanos Medical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 |
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +26.17% | Jun 21, 2023 |
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +56.46% | May 22, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +31.22% | May 4, 2023 |
Financial Forecast
Revenue This Year
709.14M
from 673.30M
Increased by 5.32%
Revenue Next Year
744.43M
from 709.14M
Increased by 4.98%
EPS This Year
1.40
from -1.33
EPS Next Year
1.84
from 1.40
Increased by 31.60%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 730.8M | 766.7M | 807.4M |
| Avg | 709.1M | 744.4M | 782.4M |
| Low | 680.8M | 714.7M | 750.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.5% | 8.1% | 8.5% |
| Avg | 5.3% | 5.0% | 5.1% |
| Low | 1.1% | 0.8% | 0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.47 | 1.90 | 2.13 | |
| Avg | 1.40 | 1.84 | 2.07 | |
| Low | 1.30 | 1.76 | 1.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 35.9% | 15.8% | |
| Avg | - | 31.6% | 12.5% | |
| Low | - | 26.1% | 8.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.